SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to news of a successful manufacturing milestone for its nasal spray, sparking significant volatility and a price surge. Community discussions revolve around potential short squeezes, resistance levels, and whether the stock can sustain its gains amidst concerns of dilution. Some traders are closely watching key price levels for potential breakouts or pullbacks, while others express skepticism about the company's long-term prospects.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as investors react to the company's CFO suggesting short sellers might face difficulties, sparking discussion of a potential short squeeze. The community is actively analyzing trading volume and options activity, anticipating further upward movement. Broader interest in critical minerals and government support for the deep-sea mining sector are also fueling the conversation.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy`s Co

Wendy's is trending amid buyout rumors and discussions of a potential short squeeze, driving community excitement. Some are hoping for a meme-stock resurgence similar to GameStop, while others speculate about a possible acquisition. The community also notes Wendy's expansion efforts and the upcoming dividend.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors analyze chart patterns and anticipate the next earnings report. Community discussions revolve around short positions, potential squeezes, and the impact of low trading volume, while some traders reference the warrants' performance and speculation around Ryan Cohen's plans.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs ($ALAB) is experiencing significant volatility, plummeting after hitting a high, with some traders attributing the drop to potential competition from new $AMD and $ORCL partnerships; others suggest this decline is an overreaction and presents a buying opportunity. Community sentiment is mixed, with some expressing frustration and accusing market manipulation, while others remain bullish on the company's fundamentals and long-term growth potential in the AI infrastructure space.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray ($TLRY) is trending due to its reverse stock split, a move met with mixed reactions from investors. While some hope it will attract institutional investors and potentially trigger a short squeeze, others express frustration with management and anticipate further price declines. The community is also actively discussing the potential impact of cannabis rescheduling on the stock.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending amid speculation of a potential chip supply partnership with Apple, driving excitement around its foundry business. The community is buzzing about what this could mean for Intel's competitiveness against rivals like AMD and TSMC, and its ability to capitalize on the AI boom. Bullish sentiment is further fueled by reported institutional accumulation and potential for a significant turnaround.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as the community rallies around its self-proclaimed 'unstoppable virus' and 'meme culture'. The coin's active and vocal community emphasizes its organic growth and 'pressure', shrugging off FUD and focusing on community engagement. Discussions highlight the coin's potential and the community's unwavering enthusiasm, with many declaring themselves 'infected' and 'bullish'.

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Janux Therapeutics Inc

JANX is trending due to positive Phase 1 clinical trial results for its prostate cancer treatment, JANX007, showing significant PSA reduction. The community is buzzing about the potential for a short squeeze and analysts raising price targets, while others express concerns about potential dilution. Some traders are noting the company's large cash position and pipeline, speculating on a possible buyout.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as discussions swirl around potential competition in the AI chip space and its relationship with Google's TPUs. The community is weighing the impact of increased competition on Broadcom's market position. Some traders point to upcoming earnings as a potential catalyst for significant movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY So say if Dr. Jay did stay on because of a request from our future partner. How would it work? Lots of details to iron out. Could we be paid with the partnering company&#39;s stock, would they make a cash investment in CYDY, and then our value is stock appreciation? Does anyone know how this might happen??

J Valro

UseToBe4RingsPatsRule

The Goof

Timothy OConnor

vivamiga

Phillip Longacre

StockTwits Web

CytoDyn Inc

 So say if Dr. Jay did stay on because of a request from our future partner. How would it work? Lots of details to iron out. Could we be paid with the partnering company's stock, would they make a cash investment in CYDY, and then our value is stock appreciation? Does anyone know how this might happen??

Mark Hayden

Robert

StockTwits for iOS

@Cytomight @DonMarko1 In general the way a partnership works is CYDY will stay intact as they are. The Big pharma partner will pay or fund part of the development of the drug for a specific indication. If CYDY had a very robust infrastructure, which we do not, CYDY would conduct the studies required for that indication using the partner&#39;s money. But,  CYDY is poor and has almost zero infrastructure. All CYDY has is the main asset LL, and provocative data. Therefore, CYDY will ask for money to help keep CYDY afloat and the Pharma partner will run the studies themselves or thru an agreed upon third party CRO, plus the partner will also receive future considerations if the trial is positive. What future considerations: The right to continue studying LL in future trials and if LL eventually gets FDA approval the partner will receive the vast majority of the revenue and CYDY will get royalties. This is VERY simple explanation, but limited space on these boards precludes further explanation

Andrew

dudu8888

mitchmiller

Jerry

 In general the way a partnership works is CYDY will stay intact as they are. The Big pharma partner will pay or fund part of the development of the drug for a specific indication. If CYDY had a very robust infrastructure, which we do not, CYDY would conduct the studies required for that indication using the partner's money. But,  CYDY is poor and has almost zero infrastructure. All CYDY has is the main asset LL, and provocative data. Therefore, CYDY will ask for money to help keep CYDY afloat and the Pharma partner will run the studies themselves or thru an agreed upon third party CRO, plus the partner will also receive future considerations if the trial is positive. What future considerations: The right to continue studying LL in future trials and if LL eventually gets FDA approval the partner will receive the vast majority of the revenue and CYDY will get royalties. This is VERY simple explanation, but limited space on these boards precludes further explanation

Go CYDY

@MLAB @Cytomight @DonMarko1 love this explanation brother.  now consider for a moment, that MD Anderson with access to keytruda, CRC patients, treatment, monitoring, CRO capabilities, sponsored the trial CYDY walked away from.  Just consider it.  Let&#39;s say the trial is successful and meets statistical significance.  CYDY accepts royalties for LL sales and MD Anderson gets the bulk?  Merck gets the benefit of increased keytruda sales because maybe it was only used as a typical PD-1 blockade and not necessarily specifically with keytruda.  Maybe MD Anderson sponsored the cancelled trial with the PD-1 blockade they had access to which was keytruda, but not necessarily in combo keytruda specifically.  If that is the case, then Merck doesn&#39;t owe anything to MD Anderson for doing the trial, but we would, and that would be the majority of the sales, but we would get royalty?

 love this explanation brother.  now consider for a moment, that MD Anderson with access to keytruda, CRC patients, treatment, monitoring, CRO capabilities, sponsored the trial CYDY walked away from.  Just consider it.  Let's say the trial is successful and meets statistical significance.  CYDY accepts royalties for LL sales and MD Anderson gets the bulk?  Merck gets the benefit of increased keytruda sales because maybe it was only used as a typical PD-1 blockade and not necessarily specifically with keytruda.  Maybe MD Anderson sponsored the cancelled trial with the PD-1 blockade they had access to which was keytruda, but not necessarily in combo keytruda specifically.  If that is the case, then Merck doesn't owe anything to MD Anderson for doing the trial, but we would, and that would be the majority of the sales, but we would get royalty?